Clinical Trials

Accrual Status
Limit to SWOG Trials

1027 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Open S1925 EVOLVE CLL 12/14/2020 40%
    Open S1931 PROBE trial 11/16/2020 28%
    Open S1933 A Pilot Study of Hypofractionated Radiotherapy Followed by Atezolizumab Consolidation in Stage II or III NSCLC Patients with Borderline Performance Status 6/15/2020 77%
    Open S1937 A Phase III Randomized Trial of Eribulin (NSC #707389) with Gemcitabine Versus Standard of Care (Physician's Choice) for Treatment of Metastatic Urothelial Carcinoma Refractory to, or Ineligible for,… 2/16/2021 15%
    Open S2000 A randomized phase 2 trial of encorafenib + binimetinib + nivolumab vs ipilimumab + nivolumab in BRAFV600-mutant melanoma brain metastases 9/23/2020 91%
    Open S2001 Parallel Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib as Maintenance Therapy in Two Cohorts of Metastatic Pancreatic Cancer Patients with DNA Damage Repair Defects 12/4/2020 55%
    Open S2005 A Phase II Randomized Study of Ibrutinib and Rituximab with or without Venetoclax in Previously Untreated Waldenstrom's Macroglobulinemia (WM) / Lymphoplasmacytic Lymphoma (LPL) 6/24/2021 3%
    Open S2007 Sacituzumab Govitecan for HER2-Neg Breast Cancer and Brain Metastases 12/15/2020 55%
    Open S2010 ASPEN 1/17/2023 52%
    Open S2012 II/III Trial of First Line Platinum/Etoposide with or without Atezolizumab in Patients with Poorly Differentiated Extrapulmonary Small Cell NEC 12/2/2021 23%
    Open S2013 I-CHECKIT 8/16/2021 99%
    Open S2101 BiCaZO - iMATCH pilot 10/14/2022 15%
    Open S2104 A Phase II Randomized Trial of Postoperative Adjuvant Capecitabine and Temozolimide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors 10/14/2021 27%
    Open S2107 Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab (NSC #748726) for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic and/or Unresectable… 6/6/2022 73%
    Open S2108CD Genomic tumor board study 8/22/2022 81%
    Open S2114 Ph II consolidation therapy following CD19 CAR-T for R/R DLBCL or Gr III FL 2/23/2023 11%
    Open S2200 S2200, A Phase II Randomized Trial of Cabozantinib with or Without Atezolizumab in Patients with Advanced Papillary Renal Cell Carcinoma: PAPMET2 9/19/2022 8%
    Open S2205 ICE COMPRESS 3/16/2023 16%
    Open S2206 A Randomized trial of neoadjuvant durvalumab plus chemotherapy versus chemotherapy alone for Adults with MammaPrint Ultrahigh (MP2) hormone receptor (HR) positive /Human Epidermal Growth Factor… 10/30/2023 1%
    Open S2207 Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment 6/30/2023 6%
    Scroll Table